Stay updated on Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added 'Thyroid gland undifferentiated (anaplastic) carcinoma' as a terminology/MeSH term in the study record. This update appears to be a metadata/terminology addition rather than a change to core study content.
    Difference
    0.0%
    Check dated 2026-03-28T03:04:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 in the site footer.
    Difference
    0.0%
    Check dated 2026-03-21T00:33:11.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision history shows the addition of Revision: v3.4.3 and deletion of Revision: v3.4.2. This change is a metadata update and does not alter study content, eligibility criteria, results, or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-03-06T18:19:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 in the website_changes section.
    Difference
    0.0%
    Check dated 2026-02-13T12:59:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:19:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Only a metadata revision was updated (Revision: v3.3.4 replacing v3.3.3); no study content or documents are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:11:14.000Z thumbnail image

Stay in the know with updates to Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.